Table 6.
Minimum tests to be performed during monitoring of the patient with PID and respiratory symptoms
| TESTS | N (Composition of panel) | Votes in agreement (%) | Degree of agreement |
|---|---|---|---|
| Patient visit every 6–12 months. | 34 (AI, AP) | 91.2 | Consensus |
| Immunological studies (complete blood count, biochemistry with LDH and Igs) every 6–12 months. | 34 (AI, AP) | 91.2 | Consensus |
| In the event of RT with gammaglobulins, IgG trough values must be measured more frequently, at least during dose adjustment. | 34 (AI, AP) | 100.0 | Unanimity |
| Respiratory tests: • Annual lung function tests are recommended every year. • Spirometry must be performed every 4–6 months in the absence of lung disease. • The sputum culture must be performed at each visit if patient is expectorating and in case of any exacerbation. |
9 (AP, PP) | 100.0 | Unanimity |
| Lung CT every 2–3 years if the patient has pulmonary involvement and every 5 years otherwise. Radiation must be minimized in case of radiosensitive ID. | 9 (AP, PP) | 100.0 | Unanimity |
| Extrapulmonary tests should be performed according to the patient’s symptoms or manifestations. | 43 (AI, PI, AP, PP) | 97.7 | Consensus |
AI: adult immunologists; AP: adult pulmonologists; ID: immunodeficiency; Ig: immunoglobulins; LDH: lactate dehydrogenase; PI: pediatric immunologists; PID: primary immunodeficiency disease; PP: pediatric pulmonologists; RT: replacement therapy